Novarsc business down while its modified generic up.

Published: 2006-09-04 07:00:00

Updated: 2006-09-04 07:00:00

The amlodipine drug market has been substantially transformed in which the original product business turned down while the sales of its modified generic version showed ever rising trend. This market also encountered a serious challenge with its isomer products, chiral amlodipine.

The sales of the amlodipine products did not show any serious impact in one year after its market launching of th...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.